A detailed history of Alliancebernstein L.P. transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 61,100 shares of SAGE stock, worth $334,828. This represents 0.0% of its overall portfolio holdings.

Number of Shares
61,100
Previous 61,100 -0.0%
Holding current value
$334,828
Previous $663,000 33.63%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 15, 2023

BUY
$40.65 - $59.54 $24,390 - $35,724
600 Added 0.99%
61,100 $2.87 Million
Q3 2022

Nov 15, 2022

SELL
$32.28 - $43.27 $2.47 Million - $3.32 Million
-76,662 Reduced 55.89%
60,500 $2.37 Million
Q2 2022

Aug 15, 2022

SELL
$27.52 - $37.99 $1.43 Million - $1.98 Million
-52,128 Reduced 27.54%
137,162 $4.43 Million
Q1 2022

May 13, 2022

BUY
$30.71 - $45.71 $1.88 Million - $2.8 Million
61,235 Added 47.82%
189,290 $6.27 Million
Q4 2021

Feb 14, 2022

BUY
$37.06 - $47.11 $1.39 Million - $1.77 Million
37,609 Added 41.58%
128,055 $5.45 Million
Q3 2021

Nov 10, 2021

BUY
$40.26 - $57.37 $2.73 Million - $3.89 Million
67,832 Added 299.96%
90,446 $4.01 Million
Q2 2021

Jul 30, 2021

SELL
$54.88 - $79.29 $47.4 Million - $68.5 Million
-863,302 Reduced 97.45%
22,614 $1.29 Million
Q1 2021

May 06, 2021

BUY
$70.65 - $96.76 $57.3 Million - $78.5 Million
811,600 Added 1092.09%
885,916 $66.3 Million
Q4 2020

Feb 08, 2021

BUY
$58.41 - $89.06 $2.84 Million - $4.34 Million
48,685 Added 189.95%
74,316 $6.43 Million
Q3 2020

Nov 12, 2020

SELL
$41.13 - $62.45 $4,113 - $6,245
-100 Reduced 0.39%
25,631 $1.57 Million
Q2 2020

Aug 13, 2020

SELL
$25.95 - $43.15 $783,949 - $1.3 Million
-30,210 Reduced 54.0%
25,731 $1.07 Million
Q1 2020

May 14, 2020

BUY
$26.15 - $77.24 $653,227 - $1.93 Million
24,980 Added 80.68%
55,941 $1.61 Million
Q4 2019

Feb 18, 2020

SELL
$60.18 - $154.77 $23.1 Million - $59.4 Million
-383,657 Reduced 92.53%
30,961 $2.24 Million
Q3 2019

Nov 14, 2019

SELL
$140.29 - $189.96 $1.97 Million - $2.66 Million
-14,025 Reduced 3.27%
414,618 $58.2 Million
Q2 2019

Aug 14, 2019

SELL
$157.85 - $183.09 $2.91 Million - $3.37 Million
-18,429 Reduced 4.12%
428,643 $78.5 Million
Q1 2019

May 14, 2019

SELL
$89.33 - $163.65 $2.18 Million - $4 Million
-24,457 Reduced 5.19%
447,072 $71.1 Million
Q4 2018

Feb 13, 2019

BUY
$81.94 - $139.71 $4.69 Million - $8 Million
57,233 Added 13.81%
471,529 $45.2 Million
Q3 2018

Nov 08, 2018

SELL
$138.11 - $169.04 $6.14 Million - $7.51 Million
-44,425 Reduced 9.68%
414,296 $58.5 Million
Q2 2018

Aug 13, 2018

SELL
$140.36 - $175.76 $10.5 Million - $13.2 Million
-74,921 Reduced 14.04%
458,721 $71.8 Million
Q1 2018

May 14, 2018

SELL
$152.15 - $192.33 $7.2 Million - $9.1 Million
-47,340 Reduced 8.15%
533,642 $86 Million
Q4 2017

Feb 13, 2018

SELL
$60.72 - $167.34 $1.41 Million - $3.89 Million
-23,237 Reduced 3.85%
580,982 $95.7 Million
Q3 2017

Nov 13, 2017

BUY
$61.4 - $88.52 $37.1 Million - $53.5 Million
604,219
604,219 $37.6 Million

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $326M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.